On May 12th, the biaseparations.com website will be retired and migrated tosartorius.com.Learn moreabout our combined offering today!
2022

PATfix HPLC analytical system is all it takes to accelerate your process development and have continuous at-line production monitoring and robust quality control of nucleic acid drug substances. Designing a correct hardware setup for reproducible analytical separation of large biomolecules is not trivial. Complex IVT mixtures are composed of target molecule (mRNA), process-related impurities (nucleotides, capping reagent, DNA template) and product-related impurities (abortive fragments, dsRNA), all with similar biophysical characteristics. These challenges make the PATfix mRNA platform a preferred analytical solution

Attachments

Full view

2021

Global demand for pDNA production is at an all time high, due to increased need from Gene Therapy ramp-up. pDNA, as an enabling product, is critical in production of mRNA, AAV and other therapeutic vectors. Increasing yield and purity in the production of pDNA is a vital step in meeting such demand. Supporting rapid process development and optimization, PATfix pDNA analytical platform is providing reliable in-process control for pDNA process development and production.

Attachments

Full view

2019

Attachments

Full view